• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转甲状腺素蛋白基因中的p.G83R突变与中国汉族家庭中的遗传性玻璃体淀粉样变性有关。

Mutation p.G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families.

作者信息

Zhang A-Mei, Wang Hui, Sun Peng, Hu Qiu-Xiang, He Yuqing, Yao Yong-Gang

机构信息

Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.

出版信息

Mol Vis. 2013 Jul 25;19:1631-8. Print 2013.

PMID:23901247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3724954/
Abstract

PURPOSE

Hereditary vitreous amyloidosis (HVA) is a genetic ophthalmological disorder. The purpose of this study was to investigate whether a mutation in the transthyretin (TTR) gene is associated with HVA in Han Chinese families.

METHODS

We performed clinical evaluation of three Han Chinese families with HVA and sequenced the entire exon of the TTR gene in probands and normal individuals from the families. The identified mutation was further genotyped in 196 unrelated healthy controls. Evolutionary conservation analysis and structural prediction were used to infer the potential pathogenicity of the mutation.

RESULTS

Clinical penetrance of HVA varied in the three families (11/30 in Family A, 8/83 in Family B, and 7/47 in Family C). A comprehensive medical examination of the patients showed no signs of abnormality except ophthalmologic symptoms, in which floccular turbidity and high echo in both vitreous bodies were observed in all probands. Further histochemical examination of the vitrectomy specimen with Congo red staining identified amyloid deposits. A heterozygous mutation c.307G>C (p.G83R) in exon 3 of the TTR gene was identified in all patients, but not in some unaffected family members. Screening of 196 unrelated normal controls revealed no presence of this mutation. This mutation changed the highly conserved glycine to arginine in the 83(rd) position and altered the tertiary structure of the TTR protein.

CONCLUSIONS

Mutation p.G83R in the TTR protein is associated with HVA in Chinese families. The seemingly specific distribution of this mutation in Han Chinese may be used for clinical diagnosis.

摘要

目的

遗传性玻璃体淀粉样变性(HVA)是一种遗传性眼科疾病。本研究旨在调查转甲状腺素蛋白(TTR)基因的突变是否与汉族家庭中的HVA相关。

方法

我们对三个患有HVA的汉族家庭进行了临床评估,并对先证者和家庭中的正常个体的TTR基因的整个外显子进行了测序。在196名无亲缘关系的健康对照中对鉴定出的突变进行了进一步的基因分型。使用进化保守性分析和结构预测来推断该突变的潜在致病性。

结果

HVA的临床外显率在三个家庭中有所不同(A家族为11/30,B家族为8/83,C家族为7/47)。对患者进行的全面医学检查显示,除眼科症状外无异常迹象,所有先证者均观察到玻璃体絮状混浊和高回声。用刚果红染色对玻璃体切除标本进行进一步的组织化学检查,发现了淀粉样沉积物。在所有患者中均鉴定出TTR基因第3外显子的杂合突变c.307G>C(p.G83R),但在一些未受影响的家庭成员中未发现。对196名无亲缘关系的正常对照进行筛查,未发现该突变。该突变将第83位高度保守的甘氨酸变为精氨酸,并改变了TTR蛋白的三级结构。

结论

TTR蛋白中的p.G83R突变与中国家庭中的HVA相关。这种突变在汉族人中看似特定的分布可用于临床诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3136/3724954/5155c25c58d8/mv-v19-1631-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3136/3724954/5155c25c58d8/mv-v19-1631-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3136/3724954/5155c25c58d8/mv-v19-1631-f1.jpg

相似文献

1
Mutation p.G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families.转甲状腺素蛋白基因中的p.G83R突变与中国汉族家庭中的遗传性玻璃体淀粉样变性有关。
Mol Vis. 2013 Jul 25;19:1631-8. Print 2013.
2
A new Arg54Gly transthyretin gene mutation associated with vitreous amyloidosis in Chinese.在中国发现一种与玻璃体淀粉样变性相关的新的转甲状腺素蛋白基因Arg54Gly突变。
Eye Sci. 2011 Dec;26(4):230-8. doi: 10.3969/j.issn.1000-4432.2011.04.010.
3
Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.一家系中国人遗传性淀粉样多神经病眼表表现,系 TTR Gly83Arg 突变所致。
Eye (Lond). 2014 Jan;28(1):26-33. doi: 10.1038/eye.2013.217. Epub 2013 Oct 11.
4
Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.载脂蛋白 A36 突变致中国家族性转甲状腺素蛋白淀粉样变性一家系玻璃体和血清血管内皮生长因子升高
Exp Eye Res. 2013 May;110:44-9. doi: 10.1016/j.exer.2013.02.005. Epub 2013 Feb 21.
5
[Identification of a TTR gene mutation in a family with hereditary vitreous amyloidosis].[遗传性玻璃体淀粉样变性家族中TTR基因突变的鉴定]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Feb;29(1):13-5. doi: 10.3760/cma.j.issn.1003-9406.2012.01.004.
6
Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.中国大陆两个大家族中由转甲状腺素蛋白变体Lys35Thr和Leu55Arg导致的玻璃体淀粉样变性。
Ophthalmic Genet. 2012 Mar;33(1):28-33. doi: 10.3109/13816810.2011.599356. Epub 2011 Aug 15.
7
A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only.仅在中国家系中表现出玻璃体淀粉样变性的新型错义突变(Gly83Arg)的小鼠模型。
Exp Eye Res. 2018 Apr;169:13-19. doi: 10.1016/j.exer.2018.01.017. Epub 2018 Feb 3.
8
Transthyretin-related hereditary amyloidosis in a Chinese family with TTR Y114C mutation.载脂蛋白相关遗传性淀粉样变性病一家系 TTR Y114C 突变
Neurodegener Dis. 2011;8(4):187-93. doi: 10.1159/000321679. Epub 2010 Dec 3.
9
Association between a point mutation at the -743-bp region of the transthyretin (TTR) gene and familial vitreous amyloidosis.转甲状腺素蛋白(TTR)基因-743-bp区域的点突变与家族性玻璃体淀粉样变性之间的关联。
Genet Mol Res. 2016 Mar 31;15(1):gmr6926. doi: 10.4238/gmr.15016926.
10
A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndrome.一种伴有玻璃体淀粉样变性和腕管综合征的新型转甲状腺素蛋白赖氨酸70谷氨酸(p.Lys90Glu)突变。
Amyloid. 2016;23(1):46-50. doi: 10.3109/13506129.2015.1126574. Epub 2016 Feb 1.

引用本文的文献

1
Effect of G83R Mutation on Transthyretin Protein Structural Stability.G83R突变对转甲状腺素蛋白结构稳定性的影响。
ACS Omega. 2025 Aug 13;10(33):37674-37686. doi: 10.1021/acsomega.5c04236. eCollection 2025 Aug 26.
2
Long-term follow-up of retinal amyloid angiopathy in a large Chinese family with hereditary amyloid transthyretin.一个患有遗传性转甲状腺素蛋白淀粉样变性的中国大家庭中视网膜淀粉样血管病的长期随访
BMC Ophthalmol. 2025 Apr 28;25(1):251. doi: 10.1186/s12886-025-04059-y.
3
Hereditary vitreoretinal amyloidosis with transthyretin Gly83Arg variant, a long-term study.

本文引用的文献

1
Transthyretin Arg-83 mutation in vitreous amyloidosis.玻璃体淀粉样变性中的转甲状腺素蛋白精氨酸-83突变
Int J Ophthalmol. 2011;4(3):329-31. doi: 10.3980/j.issn.2222-3959.2011.03.26. Epub 2011 Jun 18.
2
Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy.家族性淀粉样多神经病患者肝移植后的长期生存。
Neurology. 2012 Feb 28;78(9):637-43. doi: 10.1212/WNL.0b013e318248df18. Epub 2012 Feb 15.
3
Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients.
伴有转甲状腺素蛋白Gly83Arg变异体的遗传性玻璃体视网膜淀粉样变性:一项长期研究
Eye (Lond). 2025 Feb;39(2):345-353. doi: 10.1038/s41433-024-03445-y. Epub 2024 Oct 31.
4
The Gly103Arg variant in hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性中的Gly103Arg变体
Front Neurol. 2024 Sep 9;15:1471131. doi: 10.3389/fneur.2024.1471131. eCollection 2024.
5
Rare manifestation of familial vitreous amyloidosis caused by Gly103Arg transthyretin.由甘氨酸103精氨酸转甲状腺素蛋白引起的家族性玻璃体淀粉样变性的罕见表现。
Int J Ophthalmol. 2023 Jul 18;16(7):1093-1099. doi: 10.18240/ijo.2023.07.14. eCollection 2023.
6
Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage.病例报告:遗传性转甲状腺素蛋白(ATTRv)淀粉样变性:一个汉族家庭中转甲状腺素蛋白基因的p.G103R突变与玻璃体积血相关。
Front Genet. 2022 Sep 15;13:972501. doi: 10.3389/fgene.2022.972501. eCollection 2022.
7
Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China.中国遗传性转甲状腺素蛋白淀粉样变性患者的临床表型和遗传特征。
Orphanet J Rare Dis. 2022 Sep 2;17(1):337. doi: 10.1186/s13023-022-02481-9.
8
Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis.甘氨酸83位点精氨酸突变:超越家族性玻璃体淀粉样变性
Front Neurol. 2022 Feb 3;12:821003. doi: 10.3389/fneur.2021.821003. eCollection 2021.
9
Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.中国大陆遗传性转甲状腺素蛋白淀粉样变性:一项单中心回顾性研究。
Ann Clin Transl Neurol. 2021 Apr;8(4):831-841. doi: 10.1002/acn3.51328. Epub 2021 Mar 19.
10
Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer's Disease in Han Chinese.载脂蛋白 E 基因多态性与汉族阿尔茨海默病的相关性研究
Mol Neurobiol. 2017 Sep;54(7):5192-5200. doi: 10.1007/s12035-016-0065-2. Epub 2016 Aug 25.
中国非 Val30Met 变异型家族性淀粉样多发性神经病患者肝移植的单中心经验。
Amyloid. 2012 Mar;19(1):33-6. doi: 10.3109/13506129.2012.655867. Epub 2012 Feb 10.
4
[Identification of a TTR gene mutation in a family with hereditary vitreous amyloidosis].[遗传性玻璃体淀粉样变性家族中TTR基因突变的鉴定]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Feb;29(1):13-5. doi: 10.3760/cma.j.issn.1003-9406.2012.01.004.
5
A new Arg54Gly transthyretin gene mutation associated with vitreous amyloidosis in Chinese.在中国发现一种与玻璃体淀粉样变性相关的新的转甲状腺素蛋白基因Arg54Gly突变。
Eye Sci. 2011 Dec;26(4):230-8. doi: 10.3969/j.issn.1000-4432.2011.04.010.
6
Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.中国大陆两个大家族中由转甲状腺素蛋白变体Lys35Thr和Leu55Arg导致的玻璃体淀粉样变性。
Ophthalmic Genet. 2012 Mar;33(1):28-33. doi: 10.3109/13816810.2011.599356. Epub 2011 Aug 15.
7
Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family.一个中国家族中载脂蛋白 AV30Ala 所致家族性淀粉样多发性神经病的临床和组织病理学特征。
J Neurol Sci. 2011 May 15;304(1-2):83-6. doi: 10.1016/j.jns.2011.02.005. Epub 2011 Mar 12.
8
Transthyretin-related hereditary amyloidosis in a Chinese family with TTR Y114C mutation.载脂蛋白相关遗传性淀粉样变性病一家系 TTR Y114C 突变
Neurodegener Dis. 2011;8(4):187-93. doi: 10.1159/000321679. Epub 2010 Dec 3.
9
Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.转甲状腺素相关家族性淀粉样多发性神经病-日本熊本的进展(1967-2010)-。
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(7):694-706. doi: 10.2183/pjab.86.694.
10
A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.一例因苯丙氨酸33缬氨酸转甲状腺素蛋白引起的家族性淀粉样多神经病,以玻璃体受累为首发表现。
Intern Med. 2010;49(12):1213-6. doi: 10.2169/internalmedicine.49.3355. Epub 2010 Jun 15.